Submit manuscript

Deep Regional Hyperthermia Treatment Using Thermotron-RF8: An Initial Experience at Chulabhorn Hospital

Sunanta Rojwatkarnjana MD1, Poompis Pattaranutraporn MD1, Thong Chotchutipan MD1, Rattanaporn Nanthong BNS1, Danupon Nantajit PhD1,2, Pornwaree Trirussapanich MD1, Kanyanee Laebua MD1, Sasikarn Chamchod MD1,2

Affiliation : 1 Department of Radiation Oncology, Chulabhorn Hospital, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand 2 Faculty of Medicine and Public Health, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand

Background : Adding hyperthermia to radiation or chemotherapy has been shown to improve outcomes in patients with various malignancies.
Objective : To evaluate response rates and toxicities of deep regional hyperthermia combined with radiation or chemotherapy in cancer patients.
Materials and Methods : Medical records of 30 cancer patients treated with deep regional hyperthermia combined with radiation therapy or chemotherapy from April 2014 to April 2017 were retrospectively reviewed. Treatment outcomes were reported in terms of response rates and toxicities.
Results : The median follow-up time was 15 months (range 4 to 38 months); 53% of patients received hyperthermia combined with radiation therapy, and 37% received hyperthermia combined with chemotherapy. The most commonly treated sites were within the pelvic cavity (46.7%) and abdomen (40%). Of the 30 patients, 16.7% achieved complete response, 36.7% achieved partial response, 13.3% had stable disease, and 33.3% had progressive disease. Among patients in the curative intent group, 50% achieved complete response and 50% achieved partial response. In the palliative intent group, 30% achieved partial response, 20% had stable disease, and 50% had progressive disease. The most common toxicity was skin reaction grade 1.
Conclusion : Adding hyperthermia to radiation or chemotherapy is feasible, with minimal adverse effects. Treatment outcomes were comparable with previous published data.

Keywords : Deep regional hyperthermia; Thermotron-RF8; Radiation therapy; Chemotherapy; Response; Toxicity


All Articles Download


INFORMATION

Contact info

JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND
4th Floor, Royal Golden Jubilee Building,
2 Soi Soonvijai, New Petchburi road,
Bangkok 10310, Thailand.
Phone: 0-2716-6102, 0-2716-6962
Fax: 0-2314-6305
Email: editor@jmatonline.com

JMed Assoc Thai
MEDICAL ASSOCIATION OF THAILAND
ISSN: 0125-2208 (Print),
ISSN: 2408-1981 (Online)
The content of this site is intended for health professionals.

Submissions

» Online Submissions » Author Guidelines » Copyright Notice » Privacy Statement

Other

» Journal Sponsorship » Site Map » About this Publishing System

© MEDICAL ASSOCIATION OF THAILAND. All Rights Reserved. The content of this site is intended for health professionals.